Skip Navigation
Leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases
Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

NIAID Accomplishments

NIAID conducts and supports research to better understand, treat, and ultimately prevent infectious and immune-mediated diseases. For more than 60 years, NIAID research has led to new therapies, vaccines, diagnostic tests, and other technologies that have improved the health of millions of people in the United States and abroad. This page highlights notable scientific advances made by NIAID laboratories and NIAID-funded researchers.

photo of a child being vaccinated 

NIAID Showcase

The first NIAID Showcase highlights a history of many decades of scientific advances made by NIAID laboratories and NIAID-funded researchers at domestic and international institutions. View the NIAID Showcase.

photo of Anthony Fauci 

Selected NIAID Research Advances of 2015

This slideshow highlights notable scientific advances made by NIAID laboratories and NIAID-funded researchers at domestic and international institutions during fiscal year 2015. Some advances brought us closer to vaccines and treatments for HIV, influenza, and Ebola. Others offered new insights into food allergy prevention, autoimmune diseases, and drug-resistant infections. View the Selected NIAID Research Advances 2015.
photo of Anthony Fauci 

Selected NIAID Research Advances of 2014

This slideshow highlights notable scientific advances made by NIAID laboratories and NIAID-funded researchers at domestic and international institutions during fiscal year 2014. All are representative of how public investment in biomedical research can advance science and benefit human health. View the Selected NIAID Research Advances 2014.

photo of researchers in a lab 

Selected NIAID Research Advances of 2013

This slideshow highlights notable scientific accomplishments made by NIAID laboratories and NIAID-funded researchers at domestic and international institutions during fiscal year 2013. Some advances brought us closer to much-needed vaccines for HIV, malaria, and dengue fever, while others expanded our knowledge of newly emerging diseases such as H7N9 influenza and Middle East respiratory syndrome (MERS). View the Selected NIAID Research Advances 2013.

Last Updated March 11, 2016